Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 46

1.

Clinical Assessment of 5-Fluorouracil/Leucovorin, Nab-Paclitaxel, and Irinotecan (FOLFIRABRAX) in Untreated Patients with Gastrointestinal Cancer Using UGT1A1 Genotype-Guided Dosing.

Joshi SS, Catenacci DVT, Karrison TG, Peterson JD, Zalupski MM, Sehdev A, Wade J, Sadiq A, Picozzi VJ, Amico A, Marsh R, Kozloff MF, Polite BN, Kindler HL, Sharma MR.

Clin Cancer Res. 2020 Jan 1;26(1):18-24. doi: 10.1158/1078-0432.CCR-19-1483. Epub 2019 Sep 26.

PMID:
31558477
2.

Predictive proteomic signatures for response of pancreatic cancer patients receiving chemotherapy.

Peng H, Chen R, Brentnall TA, Eng JK, Picozzi VJ, Pan S.

Clin Proteomics. 2019 Jul 17;16:31. doi: 10.1186/s12014-019-9251-3. eCollection 2019.

3.

Multi-omic molecular comparison of primary versus metastatic pancreatic tumours.

Brar G, Blais EM, Joseph Bender R, Brody JR, Sohal D, Madhavan S, Picozzi VJ, Hendifar AE, Chung VM, Halverson D, Mikhail S, Matrisian LM, Rahib L, Petricoin E, Pishvaian MJ.

Br J Cancer. 2019 Jul;121(3):264-270. doi: 10.1038/s41416-019-0507-5. Epub 2019 Jul 11.

PMID:
31292535
4.

Results from a Phase IIb, Randomized, Multicenter Study of GVAX Pancreas and CRS-207 Compared with Chemotherapy in Adults with Previously Treated Metastatic Pancreatic Adenocarcinoma (ECLIPSE Study).

Le DT, Picozzi VJ, Ko AH, Wainberg ZA, Kindler H, Wang-Gillam A, Oberstein P, Morse MA, Zeh HJ 3rd, Weekes C, Reid T, Borazanci E, Crocenzi T, LoConte NK, Musher B, Laheru D, Murphy A, Whiting C, Nair N, Enstrom A, Ferber S, Brockstedt DG, Jaffee EM.

Clin Cancer Res. 2019 Sep 15;25(18):5493-5502. doi: 10.1158/1078-0432.CCR-18-2992. Epub 2019 May 24.

PMID:
31126960
5.

Pancreas Cancer-Associated Weight Loss.

Hendifar AE, Petzel MQB, Zimmers TA, Denlinger CS, Matrisian LM, Picozzi VJ, Rahib L; Precision Promise Consortium.

Oncologist. 2019 May;24(5):691-701. doi: 10.1634/theoncologist.2018-0266. Epub 2018 Dec 27.

6.

Molecular Profiling of Patients with Pancreatic Cancer: Initial Results from the Know Your Tumor Initiative.

Pishvaian MJ, Bender RJ, Halverson D, Rahib L, Hendifar AE, Mikhail S, Chung V, Picozzi VJ, Sohal D, Blais EM, Mason K, Lyons EE, Matrisian LM, Brody JR, Madhavan S, Petricoin EF 3rd.

Clin Cancer Res. 2018 Oct 15;24(20):5018-5027. doi: 10.1158/1078-0432.CCR-18-0531. Epub 2018 Jun 28.

7.

Initiation of adjuvant therapy following surgical resection of pancreatic ductal adenocarcinoma (PDAC): Are patients from rural, remote areas disadvantaged?

Bertens KA, Massman JD 3rd, Helton S, Garbus S, Mandelson MM, Lin B, Picozzi VJ, Biehl T, Alseidi AA, Rocha FG.

J Surg Oncol. 2018 Jun;117(8):1655-1663. doi: 10.1002/jso.25060. Epub 2018 May 14.

PMID:
29761510
8.

Does mesenteric venous imaging assessment accurately predict pathologic invasion in localized pancreatic ductal adenocarcinoma?

Clanton J, Oh S, Kaplan SJ, Johnson E, Ross A, Kozarek R, Alseidi A, Biehl T, Picozzi VJ, Helton WS, Coy D, Dorer R, Rocha FG.

HPB (Oxford). 2018 Oct;20(10):925-931. doi: 10.1016/j.hpb.2018.03.014. Epub 2018 May 10.

PMID:
29753633
9.

Gemcitabine and Taxane Adjuvant Therapy with Chemoradiation in Resected Pancreatic Cancer: A Novel Strategy for Improved Survival?

Kanji ZS, Edwards AM, Mandelson MT, Sahar N, Lin BS, Badiozamani K, Song G, Alseidi A, Biehl TR, Kozarek RA, Helton WS, Picozzi VJ, Rocha FG.

Ann Surg Oncol. 2018 Apr;25(4):1052-1060. doi: 10.1245/s10434-018-6334-8. Epub 2018 Jan 17.

PMID:
29344878
10.

Sacituzumab govitecan (IMMU-132), an anti-Trop-2-SN-38 antibody-drug conjugate for the treatment of diverse epithelial cancers: Safety and pharmacokinetics.

Ocean AJ, Starodub AN, Bardia A, Vahdat LT, Isakoff SJ, Guarino M, Messersmith WA, Picozzi VJ, Mayer IA, Wegener WA, Maliakal P, Govindan SV, Sharkey RM, Goldenberg DM.

Cancer. 2017 Oct 1;123(19):3843-3854. doi: 10.1002/cncr.30789. Epub 2017 May 30.

11.

Five-Year Actual Overall Survival in Resected Pancreatic Cancer: A Contemporary Single-Institution Experience from a Multidisciplinary Perspective.

Picozzi VJ, Oh SY, Edwards A, Mandelson MT, Dorer R, Rocha FG, Alseidi A, Biehl T, Traverso LW, Helton WS, Kozarek RA.

Ann Surg Oncol. 2017 Jun;24(6):1722-1730. doi: 10.1245/s10434-016-5716-z. Epub 2017 Jan 4.

PMID:
28054192
12.

Using Experience-Based Design to Improve the Care Experience for Patients With Pancreatic Cancer.

Hagensen A, London AE, Phillips JJ, Helton WS, Picozzi VJ, Blackmore CC.

J Oncol Pract. 2016 Dec;12(12):e1035-e1041. Epub 2016 Sep 30.

PMID:
27624947
13.

Localized pancreatic cancer with positive peritoneal cytology as a sole manifestation of metastatic disease: a single-institution experience.

Oh SY, Edwards A, Mandelson MT, Hahn H, Alseidi A, Biehl T, Kozarek RA, Rocha FG, Helton S, Picozzi VJ.

Am J Surg. 2017 Jan;213(1):94-99. doi: 10.1016/j.amjsurg.2016.04.008. Epub 2016 Jun 12.

PMID:
27424044
14.

Rare long-term survivors of pancreatic adenocarcinoma without curative resection.

Oh SY, Edwards A, Mandelson MT, Lin B, Dorer R, Helton WS, Kozarek RA, Picozzi VJ.

World J Gastroenterol. 2015 Dec 28;21(48):13574-81. doi: 10.3748/wjg.v21.i48.13574.

15.

(90)Y-clivatuzumab tetraxetan with or without low-dose gemcitabine: A phase Ib study in patients with metastatic pancreatic cancer after two or more prior therapies.

Picozzi VJ, Ramanathan RK, Lowery MA, Ocean AJ, Mitchel EP, O'Neil BH, Guarino MJ, Conkling PR, Cohen SJ, Bahary N, Frank RC, Dragovich T, Bridges BB, Braiteh FS, Starodub AN, Lee FC, Gribbin TE, Richards DA, Lee M, Korn RL, Pandit-Taskar N, Goldsmith SJ, Intenzo CM, Sheikh A, Manzone TC, Horne H, Sharkey RM, Wegener WA, O'Reilly EM, Goldenberg DM, Von Hoff DD.

Eur J Cancer. 2015 Sep;51(14):1857-64. doi: 10.1016/j.ejca.2015.06.119. Epub 2015 Jul 14.

16.

First-in-Human Trial of a Novel Anti-Trop-2 Antibody-SN-38 Conjugate, Sacituzumab Govitecan, for the Treatment of Diverse Metastatic Solid Tumors.

Starodub AN, Ocean AJ, Shah MA, Guarino MJ, Picozzi VJ Jr, Vahdat LT, Thomas SS, Govindan SV, Maliakal PP, Wegener WA, Hamburger SA, Sharkey RM, Goldenberg DM.

Clin Cancer Res. 2015 Sep 1;21(17):3870-8. doi: 10.1158/1078-0432.CCR-14-3321. Epub 2015 May 5.

17.

Interferon-based Adjuvant Chemoradiation for Resected Pancreatic Head Cancer: Long-term Follow-up of the Virginia Mason Protocol.

Rocha FG, Hashimoto Y, Traverso LW, Dorer R, Kozarek R, Helton WS, Picozzi VJ.

Ann Surg. 2016 Feb;263(2):376-84. doi: 10.1097/SLA.0000000000001190.

PMID:
25775069
18.

Should combination chemotherapy serve as the backbone in clinical trials of advanced pancreatic cancer? A pooled analysis of phase II trials of gemcitabine-containing doublets plus bevacizumab.

Van Loon K, Espinoza AM, Fogelman DR, Wolff RA, Javle MM, Iyer RV, Picozzi VJ, Martin LK, Bekaii-Saab T, Tempero MA, Foster NR, Kim GP, Ko AH.

Pancreas. 2014 Apr;43(3):343-9. doi: 10.1097/MPA.0000000000000095.

19.

Supportive care considerations during concurrent chemoradiotherapy for pancreatic adenocarcinoma: lessons learned from clinical experience.

Wang-Gillam A, Abrams RA, Posner MC, Pisters PW, Picozzi VJ.

Am J Clin Oncol. 2013 Dec;36(6):637-43. doi: 10.1097/COC.0b013e31823a53ce. Review.

PMID:
22237148
20.

Afferent limb syndrome and delayed GI problems after pancreaticoduodenectomy for pancreatic cancer: single-center, 14-year experience.

Pannala R, Brandabur JJ, Gan SI, Gluck M, Irani S, Patterson DJ, Ross AS, Dorer R, Traverso LW, Picozzi VJ, Kozarek RA.

Gastrointest Endosc. 2011 Aug;74(2):295-302. doi: 10.1016/j.gie.2011.04.029.

PMID:
21689816
21.

Standardization of surgical and pathologic variables is needed in multicenter trials of adjuvant therapy for pancreatic cancer: results from the ACOSOG Z5031 trial.

Katz MH, Merchant NB, Brower S, Branda M, Posner MC, William Traverso L, Abrams RA, Picozzi VJ, Pisters PW; American College of Surgeons Oncology Group.

Ann Surg Oncol. 2011 Feb;18(2):337-44. doi: 10.1245/s10434-010-1282-y. Epub 2010 Sep 1.

22.

Multicenter phase II trial of adjuvant therapy for resected pancreatic cancer using cisplatin, 5-fluorouracil, and interferon-alfa-2b-based chemoradiation: ACOSOG Trial Z05031.

Picozzi VJ, Abrams RA, Decker PA, Traverso W, O'Reilly EM, Greeno E, Martin RC, Wilfong LS, Rothenberg ML, Posner MC, Pisters PW; American College of Surgeons Oncology Group.

Ann Oncol. 2011 Feb;22(2):348-54. doi: 10.1093/annonc/mdq384. Epub 2010 Jul 29.

23.

Combined modality treatment of resectable and borderline resectable pancreas cancer: expert consensus statement.

Abrams RA, Lowy AM, O'Reilly EM, Wolff RA, Picozzi VJ, Pisters PW.

Ann Surg Oncol. 2009 Jul;16(7):1751-6. doi: 10.1245/s10434-009-0413-9. Epub 2009 Apr 24. No abstract available.

PMID:
19390900
24.

Strength of the evidence: adjuvant therapy for resected pancreatic cancer.

Picozzi VJ, Pisters PW, Vickers SM, Strasberg SM.

J Gastrointest Surg. 2008 Apr;12(4):657-61. Epub 2007 Dec 22. Review.

PMID:
18157582
25.

Bleeding disorders in premenopausal women: (another) public health crisis for hematology?

James AH, Ragni MV, Picozzi VJ.

Hematology Am Soc Hematol Educ Program. 2006:474-85. Review.

PMID:
17124102
26.

Anemia in the elderly: a public health crisis in hematology.

Guralnik JM, Ershler WB, Schrier SL, Picozzi VJ.

Hematology Am Soc Hematol Educ Program. 2005:528-32.

PMID:
16304431
27.

Gemcitabine combined with docetaxel for the treatment of unresectable pancreatic carcinoma.

Jacobs AD, Otero H, Picozzi VJ Jr, Aboulafia DM.

Cancer Invest. 2004;22(4):505-14.

PMID:
15565807
28.

The Virginia Mason approach to localized pancreatic cancer.

Picozzi VJ, Traverso LW.

Surg Oncol Clin N Am. 2004 Oct;13(4):663-74, ix. Review.

PMID:
15350940
29.

Phase 1 trial of a novel anti-CD20 fusion protein in pretargeted radioimmunotherapy for B-cell non-Hodgkin lymphoma.

Forero A, Weiden PL, Vose JM, Knox SJ, LoBuglio AF, Hankins J, Goris ML, Picozzi VJ, Axworthy DB, Breitz HB, Sims RB, Ghalie RG, Shen S, Meredith RF.

Blood. 2004 Jul 1;104(1):227-36. Epub 2004 Mar 2.

PMID:
14996706
30.

Interferon-based adjuvant chemoradiation therapy after pancreaticoduodenectomy for pancreatic adenocarcinoma.

Picozzi VJ, Kozarek RA, Traverso LW.

Am J Surg. 2003 May;185(5):476-80.

PMID:
12727570
31.

Patterns of chemotherapy administration in patients with intermediate-grade non-Hodgkin's lymphoma.

Picozzi VJ, Pohlman BL, Morrison VA, Lawless GD, Lee MW, Kerr RO, Ford JM, Delgado DJ, Fridman M, Carter WB.

Oncology (Williston Park). 2001 Oct;15(10):1296-306; discussion 1310-1, 1314.

32.

Novel approaches to postoperative chemoradiation therapy in pancreatic cancer.

Picozzi VJ.

J Gastrointest Surg. 2001 Jan-Feb;5(1):8-9. Review. No abstract available.

PMID:
11370619
33.
34.
35.

Tc-99m MDP detection of diffuse metastatic involvement of the liver by salivary gland mucoepidermoid carcinoma.

Coates GG, Eisenberg B, Wong SC, Yarington CT Jr, Picozzi VJ Jr.

Clin Nucl Med. 1995 Nov;20(11):1018-9. No abstract available.

PMID:
8565358
36.

Cardiac tamponade due to primary pericardial lymphoma in a patient with AIDS.

Aboulafia DM, Bush R, Picozzi VJ.

Chest. 1994 Oct;106(4):1295-9. Review.

PMID:
7924524
37.

Lymphoblastic lymphoma.

Picozzi VJ Jr.

Cancer Treat Res. 1993;66:81-94. Review. No abstract available.

PMID:
8102865
38.

Lymphoblastic lymphoma.

Picozzi VJ Jr, Coleman CN.

Semin Oncol. 1990 Feb;17(1):96-103. Review. No abstract available.

PMID:
2406921
39.

Perianal Paget's disease: successful treatment with combined chemoradiotherapy. Report of a case.

Thirlby RC, Hammer CJ Jr, Galagan KA, Travaglini JJ, Picozzi VJ Jr.

Dis Colon Rectum. 1990 Feb;33(2):150-2.

PMID:
2153511
40.

Small lymphocytic lymphoma.

Morrison WH, Hoppe RT, Weiss LM, Picozzi VJ Jr, Horning SJ.

J Clin Oncol. 1989 May;7(5):598-606.

PMID:
2651577
41.

Treatment of lymphoblastic lymphoma in adults.

Coleman CN, Picozzi VJ Jr, Cox RS, McWhirter K, Weiss LM, Cohen JR, Yu KP, Rosenberg SA.

J Clin Oncol. 1986 Nov;4(11):1628-37.

PMID:
3772416
42.

13-cis retinoic acid treatment for myelodysplastic syndromes.

Picozzi VJ Jr, Swanson GF, Morgan R, Hecht F, Greenberg PL.

J Clin Oncol. 1986 Apr;4(4):589-95.

PMID:
3514807
43.

Lymphoblastic lymphoma: an immunophenotype study of 26 cases with comparison to T cell acute lymphoblastic leukemia.

Weiss LM, Bindl JM, Picozzi VJ, Link MP, Warnke RA.

Blood. 1986 Feb;67(2):474-8.

PMID:
3080041
44.

Bleomycin, mitomycin, and cisplatin therapy for advanced squamous carcinoma of the uterine cervix: a phase II study of the Northern California Oncology Group.

Picozzi VJ Jr, Sikic BI, Carlson RW, Koretz M, Ballon SC.

Cancer Treat Rep. 1985 Jul-Aug;69(7-8):903-5.

PMID:
2410123
45.
46.

Fate of therapy failures in adult idiopathic thrombocytopenic purpura.

Picozzi VJ, Roeske WR, Creger WP.

Am J Med. 1980 Nov;69(5):690-4.

PMID:
7192052

Supplemental Content

Loading ...
Support Center